- Report
- October 2024
- 199 Pages
Global
From €3365EUR$3,545USD£2,839GBP
€3739EUR$3,939USD£3,154GBP
- Report
- November 2024
- 120 Pages
Global
From €5649EUR$5,950USD£4,765GBP
- Report
- February 2025
- 200 Pages
Global
From €4262EUR$4,490USD£3,595GBP
- Report
- September 2023
- 231 Pages
Global
From €4847EUR$5,284USD£3,950GBP
- Report
- July 2023
- 140 Pages
Global
From €4698EUR$4,949USD£3,963GBP
- Report
- December 2024
- 85 Pages
Spain
From €3323EUR$3,500USD£2,803GBP
- Report
- January 2022
- 177 Pages
Global
From €4272EUR$4,500USD£3,603GBP
- Report
- February 2024
- 119 Pages
Global
From €4509EUR$4,750USD£3,804GBP
- Report
- November 2023
- 80 Pages
France
From €3323EUR$3,500USD£2,803GBP
- Report
- November 2023
- 70 Pages
Germany
From €3323EUR$3,500USD£2,803GBP
- Report
- March 2024
- 132 Pages
Global
From €902EUR$950USD£761GBP
In Silico Clinical Trials are a type of clinical trial that uses computer simulations and models to evaluate the safety and efficacy of a drug or medical device. This type of trial is conducted virtually, without the need for physical testing on humans or animals. It is used to assess the safety and efficacy of a drug or device before it is tested on humans. In Silico Clinical Trials can be used to reduce the cost and time associated with traditional clinical trials, as well as to reduce the risk of adverse events.
In Silico Clinical Trials are becoming increasingly popular in the clinical trial industry, as they offer a cost-effective and efficient way to evaluate the safety and efficacy of a drug or device. They are also used to identify potential drug-drug interactions and to assess the potential for drug-drug interactions.
Companies in the In Silico Clinical Trials market include Simulations Plus, Certara, Entelos, and In Silico Biosciences. Show Less Read more